These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 29462176)

  • 1. Outcome of Enterococcus faecalis infective endocarditis according to the length of antibiotic therapy: Preliminary data from a cohort of 78 patients.
    Pericàs JM; Cervera C; Moreno A; Garcia-de-la-Mària C; Almela M; Falces C; Quintana E; Vidal B; Llopis J; Fuster D; Mestres CA; Marco F; Miró JM;
    PLoS One; 2018; 13(2):e0192387. PubMed ID: 29462176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ampicillin plus ceftriaxone is as effective as ampicillin plus gentamicin for treating enterococcus faecalis infective endocarditis.
    Fernández-Hidalgo N; Almirante B; Gavaldà J; Gurgui M; Peña C; de Alarcón A; Ruiz J; Vilacosta I; Montejo M; Vallejo N; López-Medrano F; Plata A; López J; Hidalgo-Tenorio C; Gálvez J; Sáez C; Lomas JM; Falcone M; de la Torre J; Martínez-Lacasa X; Pahissa A
    Clin Infect Dis; 2013 May; 56(9):1261-8. PubMed ID: 23392394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in the treatment of Enterococcus faecalis infective endocarditis in Spain in the last 15 years: from ampicillin plus gentamicin to ampicillin plus ceftriaxone.
    Pericas JM; Cervera C; del Rio A; Moreno A; Garcia de la Maria C; Almela M; Falces C; Ninot S; Castañeda X; Armero Y; Soy D; Gatell JM; Marco F; Mestres CA; Miro JM;
    Clin Microbiol Infect; 2014 Dec; 20(12):O1075-83. PubMed ID: 25040215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outpatient parenteral antimicrobial therapy in Enterococcus faecalis infective endocarditis.
    Gil-Navarro MV; Lopez-Cortes LE; Luque-Marquez R; Galvez-Acebal J; de Alarcon-Gonzalez A
    J Clin Pharm Ther; 2018 Apr; 43(2):220-223. PubMed ID: 29030859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Four weeks versus six weeks of ampicillin plus ceftriaxone in Enterococcus faecalis native valve endocarditis: A prospective cohort study.
    Ramos-Martínez A; Pericàs JM; Fernández-Cruz A; Muñoz P; Valerio M; Kestler M; Montejo M; Fariñas MC; Sousa D; Domínguez F; Ojeda-Burgos G; Plata A; Vidal L; Miró JM;
    PLoS One; 2020; 15(8):e0237011. PubMed ID: 32745091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Dual β-Lactam therapy to penicillin-aminoglycoside combination in treatment of Enterococcus faecalis infective endocarditis.
    El Rafei A; DeSimone DC; Narichania AD; Sohail MR; Vikram HR; Li Z; Steckelberg JM; Wilson WR; Baddour LM
    J Infect; 2018 Nov; 77(5):398-404. PubMed ID: 29969596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Success of ampicillin plus ceftriaxone rescue therapy for a relapse of Enterococcus faecalis native-valve endocarditis and in vitro data on double beta-lactam activity.
    Miro JM; Cervera C; Garcia-de-la-Maria C; Del Rio A; Armero Y; Mestres CA; Grau JM; Marco F; Moreno A
    Scand J Infect Dis; 2008; 40(11-12):968-72. PubMed ID: 18767002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of penicillin-gentamicin and dual beta-lactam therapies in Enterococcus faecalis infective endocarditis.
    Freeman L; Milkovits A; McDaniel L; Everson N
    Int J Antimicrob Agents; 2022 Mar; 59(3):106522. PubMed ID: 35038556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of the combination ampicillin plus ceftriaxone in the treatment of a case of enterococcal endocarditis due to Enterococcus faecalis highly resistant to gentamicin: efficacy of the "ex vivo" synergism method.
    Tascini C; Doria R; Leonildi A; Martinelli C; Menichetti F
    J Chemother; 2004 Aug; 16(4):400-3. PubMed ID: 15332717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enterococcal endocarditis revisited.
    Pericás JM; Zboromyrska Y; Cervera C; Castañeda X; Almela M; Garcia-de-la-Maria C; Mestres C; Falces C; Quintana E; Ninot S; Llopis J; Marco F; Moreno A; Miró JM
    Future Microbiol; 2015; 10(7):1215-40. PubMed ID: 26118390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of ampicillin combined with ceftriaxone and gentamicin in the treatment of experimental endocarditis due to Enterococcus faecalis with no high-level resistance to aminoglycosides.
    Gavaldá J; Onrubia PL; Gómez MT; Gomis X; Ramírez JL; Len O; Rodríguez D; Crespo M; Ruíz I; Pahissa A
    J Antimicrob Chemother; 2003 Sep; 52(3):514-7. PubMed ID: 12917251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Enterococcus faecalis Endocarditis Treatment on Risk of Relapse.
    Danneels P; Hamel JF; Picard L; Rezig S; Martinet P; Lorleac'h A; Talarmin JP; Buzelé R; Guimard T; Le Moal G; Brochard-Libois J; Beaudron A; Letheulle J; Codde C; Chenouard R; Boutoille D; Lemaignen A; Bernard L; Cattoir V; Dubée V;
    Clin Infect Dis; 2023 Jan; 76(2):281-290. PubMed ID: 36124844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brief communication: treatment of Enterococcus faecalis endocarditis with ampicillin plus ceftriaxone.
    Gavaldà J; Len O; Miró JM; Muñoz P; Montejo M; Alarcón A; de la Torre-Cisneros J; Peña C; Martínez-Lacasa X; Sarria C; Bou G; Aguado JM; Navas E; Romeu J; Marco F; Torres C; Tornos P; Planes A; Falcó V; Almirante B; Pahissa A
    Ann Intern Med; 2007 Apr; 146(8):574-9. PubMed ID: 17438316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enterococcus faecalis infective endocarditis: focus on clinical aspects.
    Dahl A; Bruun NE
    Expert Rev Cardiovasc Ther; 2013 Sep; 11(9):1247-57. PubMed ID: 24073680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early in vitro development of daptomycin non-susceptibility in high-level aminoglycoside-resistant Enterococcus faecalis predicts the efficacy of the combination of high-dose daptomycin plus ampicillin in an in vivo model of experimental endocarditis.
    Pericàs JM; García-de-la-Mària C; Brunet M; Armero Y; García-González J; Casals G; Almela M; Quintana E; Falces C; Ninot S; Fuster D; Llopis J; Marco F; Moreno A; Miró JM;
    J Antimicrob Chemother; 2017 Jun; 72(6):1714-1722. PubMed ID: 28204495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enterococcus faecalis infective endocarditis: a pilot study of the relationship between duration of gentamicin treatment and outcome.
    Dahl A; Rasmussen RV; Bundgaard H; Hassager C; Bruun LE; Lauridsen TK; Moser C; Sogaard P; Arpi M; Bruun NE
    Circulation; 2013 Apr; 127(17):1810-7. PubMed ID: 23543002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of Ceftriaxone and Ampicillin for the Treatment of Enterococcal Endocarditis: A Qualitative Systematic Review.
    Peterson SC; Lau TTY; Ensom MHH
    Ann Pharmacother; 2017 Jun; 51(6):496-503. PubMed ID: 28166656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time to abandon ampicillin plus gentamicin in favour of ampicillin plus ceftriaxone in Enterococcus faecalis infective endocarditis? A meta-analysis of comparative trials.
    Mirna M; Topf A; Schmutzler L; Hoppe UC; Lichtenauer M
    Clin Res Cardiol; 2022 Oct; 111(10):1077-1086. PubMed ID: 34751788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacodynamics of Ceftaroline plus Ampicillin against Enterococcus faecalis in an
    Werth BJ; Shireman LM
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28096164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is Once-Daily High-Dose Ceftriaxone plus Ampicillin an Alternative for Enterococcus faecalis Infective Endocarditis in Outpatient Parenteral Antibiotic Therapy Programs?
    Herrera-Hidalgo L; de Alarcón A; López-Cortes LE; Luque-Márquez R; López-Cortes LF; Gutiérrez-Valencia A; Gil-Navarro MV
    Antimicrob Agents Chemother; 2020 Dec; 65(1):. PubMed ID: 33046488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.